Viewing Study NCT00684268

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:25 PM
Ignite Modification Date: 2026-02-25 @ 7:03 PM
Study NCT ID: NCT00684268
Status: COMPLETED
Last Update Posted: 2017-03-27
First Post: 2008-05-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders
Sponsor: Medical University of Vienna
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None silibinin View
None chronic hepatitis C View
None peginterferon View
None ribavirin View
None nonresponders View
None efficacy of iv. silibinin View
None safety View